Think of Xiidra as an Alternative to Restasis for Dry Eye Disease

March 2018

Xiidra (ZYE-druh, lifitegrast) will compete with Restasis (cyclosporine) for dry eye disease.

Both Rx eye drops decrease inflammation related to dry eye disease...and modestly improve symptoms.

But there's not enough evidence to say if one works best.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Obesity & Weight Loss Help Patients With Med Adjustments After Weight Loss Surgery
Influenza Don't Rely on Supplements Instead of Antivirals to Treat Influenza
Med Adherence Partner With Patients to Improve Med Adherence
Vaccines Explain That Trumenba and Bexsero Only Protect Against Meningitis B
Hyperglycemia Assist Diabetes Patients With Glucose Bumps Due to Short-Course Steroids
Pregnancy Weigh Pros and Cons of Antibiotic Options for UTI in Pregnancy
Practice Always Shred When Disposing of Patient Info to Avoid Privacy Violations
Ophthalmics Think of Xiidra as an Alternative to Restasis for Dry Eye Disease
Multiple Sclerosis Suggest Mavenclad as a Second-Line Option for Multiple Sclerosis
Poison Prevention Be Ready With Tips to Help Prevent and Manage Poisonings